We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Oncology · CPC catalog code CANC-006
Full physicochemical data (sequence, molecular formula, molecular weight, CAS) is documented on the upstream certificate of analysis. Request the current lot COA from the supplier before use — values may vary between manufacturing runs.
Reference standards in the Oncology class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
[Lys(Ac)382]-p53 (372-389), biotin labeled sits within the Oncology research class (CPC reference CANC-006). Oncology peptides serve as tumor-targeting ligands (RGD, bombesin, somatostatin analogues), pro-apoptotic mimetics (BH3), or antigenic epitopes for T-cell recognition. Effects are read out in cell viability, receptor binding, and tumor-model contexts. Investigators typically incorporate [Lys(Ac)382]-p53 (372-389), biotin labeled as a reference standard, tool ligand, or substrate in the assay contexts listed above. MTT / CellTiter-Glo viability, caspase-3/7 activation, and receptor-binding SPR.
[Lys(Ac)382]-p53 (372-389), biotin labeled (CPC catalog code CANC-006) is a synthetic oncology research peptide in the oncology category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use [Lys(Ac)382]-p53 (372-389), biotin labeled as a reference standard in oncology workflows — for example, receptor-targeted drug-delivery research and apoptosis and cell-viability assays. Human clinical evidence is not established.
No. [Lys(Ac)382]-p53 (372-389), biotin labeled is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a oncology workflow, [Lys(Ac)382]-p53 (372-389), biotin labeled is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. MTT / CellTiter-Glo viability, caspase-3/7 activation, and receptor-binding SPR.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.